No black box warning on record for Acyclovir

As of the latest FDA labeling reviewed, Acyclovir (ACYCLOVIR) does not carry a black box warning. Standard warnings and precautions still apply — see the full Acyclovir medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Acyclovir capsules are intended for oral ingestion only. Renal failure, in some cases resulting in death, has been observed with acyclovir therapy (see ADVERSE REACTIONS: Observed During Clinical Practice and OVERDOSAGE ). Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS), which has resulted in death, has occurred in immunocompromised patients receiving acyclovir the

No black box warning on record for Acyclovir

Other warnings & precautions

WARNINGS Acyclovir capsules are intended for oral ingestion only. Renal failure, in some cases resulting in death, has been observed with acyclovir therapy (see ADVERSE REACTIONS: Observed During Clinical Practice and OVERDOSAGE ). Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS), which has resulted in death, has occurred in immunocompromised patients receiving acyclovir the

Acyclovir Black Box Warning

No black box warning on record for Acyclovir

Other warnings & precautions

Acyclovir Black Box Warning

No black box warning on record for Acyclovir

Other warnings & precautions